Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 22 04:00PM ET
0.0601
Dollar change
-0.0009
Percentage change
-1.48
%
Index- P/E- EPS (ttm)-1.18 Insider Own16.02% Shs Outstand54.45M Perf Week0.33%
Market Cap3.27M Forward P/E- EPS next Y- Insider Trans0.23% Shs Float45.73M Perf Month-73.80%
Income-26.77M PEG- EPS next Q-0.03 Inst Own5.00% Short Float0.22% Perf Quarter-77.65%
Sales20.35M P/S0.16 EPS this Y- Inst Trans-22.05% Short Ratio0.06 Perf Half Y-87.24%
Book/sh0.86 P/B0.07 EPS next Y- ROA-78.14% Short Interest0.10M Perf Year-93.61%
Cash/sh0.35 P/C0.17 EPS next 5Y- ROE-85.87% 52W Range0.06 - 1.40 Perf YTD-77.86%
Dividend Est.- P/FCF- EPS past 5Y54.97% ROI-118.87% 52W High-95.71% Beta-1.08
Dividend TTM- Quick Ratio4.11 Sales past 5Y565.10% Gross Margin35.06% 52W Low0.33% ATR (14)0.02
Dividend Ex-Date- Current Ratio5.00 EPS Y/Y TTM-102.31% Oper. Margin-42.43% RSI (14)17.52 Volatility6.70% 12.02%
Employees46 Debt/Eq0.03 Sales Y/Y TTM4046.13% Profit Margin-131.52% Recom1.00 Target Price3.00
Option/ShortNo / Yes LT Debt/Eq0.03 EPS Q/Q67.10% Payout- Rel Volume5.65 Prev Close0.06
Sales Surprise-0.71% EPS Surprise33.33% Sales Q/Q4385.93% EarningsNov 14 AMC Avg Volume1.75M Price0.06
SMA20-67.67% SMA50-73.64% SMA200-84.22% Trades Volume9,192,467 Change-1.48%
Feb-15-24 09:15AM
Feb-13-24 09:00AM
Dec-04-23 08:30AM
Nov-13-23 08:30AM
Sep-21-23 09:05PM
08:30AM Loading…
Aug-11-23 08:30AM
May-16-23 02:15PM
09:58AM
May-12-23 08:00AM
May-11-23 09:00AM
Apr-05-23 08:00AM
Feb-28-23 07:30AM
Feb-10-23 07:35AM
Jan-19-23 07:30AM
Dec-27-22 08:00AM
08:00AM Loading…
Dec-20-22 08:00AM
Nov-23-22 11:20AM
Nov-16-22 10:12AM
08:00AM
Nov-13-22 07:52AM
Nov-07-22 09:28AM
Oct-20-22 08:00AM
07:32AM
Aug-08-22 08:15AM
Aug-04-22 08:00AM
Jul-28-22 08:10AM
Jun-27-22 05:30AM
Apr-28-22 04:50PM
09:20AM
Apr-26-22 08:13AM
12:41AM Loading…
12:41AM
Apr-25-22 08:00AM
Apr-19-22 06:45PM
02:02PM
Apr-08-22 09:44AM
Apr-05-22 03:45PM
01:41PM
08:00AM
07:30AM
Mar-15-22 09:45AM
Mar-14-22 06:12PM
Mar-10-22 09:17AM
Feb-25-22 08:00AM
Feb-17-22 10:40AM
10:07AM
Feb-15-22 09:00AM
Dec-22-21 08:52AM
Nov-03-21 12:35PM
Oct-06-21 08:00AM
Aug-12-21 09:00AM
Jul-27-21 09:00AM
Jul-20-21 09:00AM
Jul-08-21 09:00AM
Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. It is also involved in the development and commercialization of science-based nutritional supplements. The firm's product includes treatment for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Slilaty Steve N.Chief Executive OfficerFeb 08Buy0.1020,0002,00030,000Feb 12 04:05 PM